Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 4Lymphoma, Non-Hodgkin 3Triple Negative Breast Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Lymphoma 2Glioblastoma 2Burkitt Lymphoma 2Sarcoma, Synovial 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Liposarcoma, Myxoid 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Ganglioneuroblastoma 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Biopsy 4Nivolumab 3sodium-iodide symporter 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Cyclosporine 210-propargyl-10-deazaaminopterin 2treosulfan 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1duvelisib 1ceritinib 1belinostat 1alectinib 1Vincristine 1Vinblastine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Leukapheresis × 90 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡